In This Article:
As the ASX200 experiences a modest rise of 0.25% to 8,505 points, with Industrials leading the charge among sectors, investors are keeping a keen eye on growth opportunities within the Australian market. Amidst these conditions, companies with high insider ownership often attract attention for their potential alignment of management interests with shareholders, making them intriguing prospects for those seeking growth in this evolving landscape.
Top 10 Growth Companies With High Insider Ownership In Australia
| Name | Insider Ownership | Earnings Growth |
| Clinuvel Pharmaceuticals (ASX:CUV) | 10.4% | 26.2% |
| SKS Technologies Group (ASX:SKS) | 29.7% | 24.8% |
| Medallion Metals (ASX:MM8) | 13.8% | 67.5% |
| Acrux (ASX:ACR) | 14.6% | 91.8% |
| Emerald Resources (ASX:EMR) | 18.1% | 34.7% |
| Newfield Resources (ASX:NWF) | 31.5% | 72.1% |
| AVA Risk Group (ASX:AVA) | 15.8% | 77.3% |
| Pointerra (ASX:3DP) | 23.8% | 126.4% |
| Plenti Group (ASX:PLT) | 12.7% | 120.1% |
| Findi (ASX:FND) | 35.8% | 111.4% |
Let's uncover some gems from our specialized screener.
Champion Iron
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Champion Iron Limited focuses on the acquisition, exploration, development, and production of iron ore deposits in Canada with a market capitalization of A$3.03 billion.
Operations: The company's revenue is primarily derived from its Iron Ore Concentrate segment, amounting to CA$1.51 billion.
Insider Ownership: 11.5%
Champion Iron's recent earnings reveal a decline, with third-quarter net income dropping significantly year-over-year. Despite this, the company is poised for growth through its partnership with Nippon Steel and Sojitz Corporation on the Kamistiatusset Project, potentially receiving up to $490 million in contributions. While facing high debt levels and lower profit margins, Champion Iron's revenue is forecasted to grow faster than the Australian market, supported by significant expected earnings growth over the next three years.
Nanosonics
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Nanosonics Limited is an infection prevention company operating globally with a market cap of A$1.01 billion.
Operations: The company's revenue segment includes Healthcare Equipment, generating A$170.01 million.
Insider Ownership: 15.3%
Nanosonics is poised for significant earnings growth, forecasted at 24.3% annually, outpacing the Australian market. However, its profit margin has decreased from last year. Despite trading below estimated fair value and having low expected return on equity (11.7%), revenue growth surpasses the market average. The recent addition of Gerard Dalbosco as an Independent Non-Executive Director brings valuable expertise in mergers and acquisitions, enhancing governance and strategic capabilities at Nanosonics.